McIlrath & Eck’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-9
Closed -$2.37K 916
2023
Q1
$2.37K Buy
+9
New +$2.29K ﹤0.01% 762
2020
Q1
Sell
-75
Closed -$11K 680
2019
Q4
$11K Hold
75
0.01% 353
2019
Q3
$9K Hold
75
﹤0.01% 368
2019
Q2
$10K Hold
75
0.01% 333
2019
Q1
$10K Hold
75
0.01% 333
2018
Q4
$9K Hold
75
0.01% 282
2018
Q3
$10K Hold
75
0.01% 284
2018
Q2
$8K Hold
75
﹤0.01% 304
2018
Q1
$7K Hold
75
﹤0.01% 305
2017
Q4
$7K Buy
+75
New +$6.03K ﹤0.01% 320

Other funds holding HCA

McIlrath & Eck's HCA Position: Q2 2023 in Review

McIlrath & Eck sold out of HCA Healthcare (HCA) in Q2 2023, closing a stake of 9 shares — an estimated $2.37K sold.

McIlrath & Eck first reported a position in HCA in Q4 2017 and held it in 10 quarters. The position peaked at $11K in Q4 2019. 1,012 funds tracked by Wall St. Rank hold HCA as of Q2 2023.

  • McIlrath & Eck reported no remaining HCA Healthcare position as of Q2 2023 after selling out during the quarter.
  • McIlrath & Eck sold 9 HCA Healthcare shares in Q2 2023, an estimated $2.37K.
  • McIlrath & Eck first reported a position in HCA Healthcare in Q4 2017 and held it in 10 quarters.
  • McIlrath & Eck's HCA Healthcare position peaked at $11K in Q4 2019.
  • 1,012 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2023.

Based on McIlrath & Eck's 13F filing for Q2 2023, filed 7 Aug 2023.